ICH E22 Guideline on general considerations for patient preference studies

1:1
Open for consultation from 12 December to 12 April, this draft ICH guideline sets out how to design and submit robust patient preference studies to inform regulatory decision‑making across a medicine’s lifecycle.

This harmonised draft guideline explains how patient preference studies (PPS) can be designed, conducted, analysed and submitted to support drug development and regulatory evaluation, including benefit–risk assessment and maintenance of approvals. It clarifies that PPS generate structured insights into what matters most to patients when weighing treatment attributes such as outcomes, risks and other relevant characteristics, and provides general methodological considerations intended to improve the quality and usability of patient preference information in regulatory contexts.

Acces this publication (pdf)
Publication cover image

Year of publication

2025

Source

European Medicines Agency (EMA)

Link to cite

Acces to Link >

Author

You might also be interested in

Captura de pantalla 2026-03-10 165055

The Health Research Podcast – Ep 6: Rare Disease Research

European Parliament

European Parliament draft report urges a binding EU rare disease action framework

A legislative own initiative file in the Parliament’s new public health committee sets out what an EU “rare disease action framework” could look like — and why it could change how Europe measures progress for patients.
Woman helping out a person with a disease

Women’s Day highlights widening gender inequalities in rare diseases

Drawing on Europe-wide patient and carer surveys, ERDERA highlights how gender can shape diagnostic delays, care burden and the evidence base for rare-disease research.
European Parliament Photograph

New European Parliament study maps options for an EU rare disease action plan

European Parliament research service assessment, published in February 2026, identifies 31 measures that could form an EU rare disease action plan, highlighting European Reference Networks and cross-border collaboration including ERDERA as drivers of EU added value.

ERDERA's

search form